Skip to main content
Terug
Watch Compare

Syra Health Corp

Datakwaliteit: 100%
SYRA
OTC Services Business Services
€ 0,35
▲ € 0,04 (12,65%)
Marktkapitalisatie: 3,71 M
Prijs
€ 0,31
Marktkapitalisatie
3,71 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -447.853,0
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-9,47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-38,77%
Onder sectorgemiddelde (-15,95%)
ROIC-30,90%
Net Margin-12,40%
Op. Margin-12,51%

Veiligheid

Debt / Equity
N/A
Current Ratio3,05
Interest Coverage-68,15

Waardering

PE (TTM)
-4,14
Onder sectorgemiddelde (-1,17)
P/B Ratio1,68
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -4,1 -1,2
P/B 1,7 1,4
ROE % -38,8 -16,0
Net Margin % -12,4 -19,4
Rev Growth 5Y % — 4,0
D/E — 0,4

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2026 — 0,0 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -9,47% Revenue Growth (3Y) 14,46%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7,23 M Net Income (TTM) -896.333,0
ROE -38,77% ROA -26,62%
Gross Margin 34,43% Operating Margin -12,51%
Net Margin -12,40% Free Cash Flow (TTM) -447.853,0
ROIC -30,90% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,05
Interest Coverage -68,15 Asset Turnover 2,15
Working Capital 2,16 M Tangible Book Value 2,21 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,14 Forward P/E N/A
P/B Ratio 1,68 P/S Ratio 0,51
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -12,08%
Market Cap 3,71 M Enterprise Value 1,73 M
Per Share
EPS (Diluted TTM) -0,08 Revenue / Share 0,61
FCF / Share -0,04 OCF / Share -0,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 49,97%
SBC-Adj. FCF -523.047 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 7,23 M 7,98 M 5,52 M
Net Income -896.333,0 -3,76 M -2,94 M
EPS (Diluted) -0,08 -0,50 -0,60
Gross Profit 2,49 M 1,65 M 1,41 M
Operating Income -904.324,0 -3,76 M -2,89 M
EBITDA — — —
R&D Expenses 67.840,0 585.146,0 240.048,0
SG&A Expenses 1,07 M 1,45 M 1,13 M
D&A — — —
Interest Expense 13.270,0 15.600,0 53.686,0
Income Tax 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 2,77 M 3,68 M 4,92 M
Total Liabilities 674.739,0 800.761,0 910.072,0
Shareholders' Equity 2,10 M 2,88 M 4,01 M
Total Debt — — —
Cash & Equivalents 1,61 M 2,40 M 3,28 M
Current Assets 2,74 M 3,35 M 4,78 M
Current Liabilities 674.739,0 613.549,0 910.072,0